Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by نيوفارما ريسرتش سويدن ايه بيfiledCriticalنيوفارما ريسرتش سويدن ايه بي
Priority to JO200284ApriorityCriticalpatent/JO2214B1/en
Application grantedgrantedCritical
Publication of JO2214B1publicationCriticalpatent/JO2214B1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
The present Invention provldes a solution to the aforementioned problems. The aforementioned object is achieved by a micellar composition having the (attires defined in claim 1 and comprising as an essential active ingredient rafoxanide and a combination of solvents which act as a stabilizing and absorptlon-pnnoting agent the combination being selected from a group consisting of specific combinations of a nonlonic surface active agent such as Tween® S 80 with N- methylpyrrolidone (NMP), 2-pyrroildone, dimetbylsulfoxlde (DMSO), or specific combinations thereaf
JO200284A2002-08-072002-08-07Veterinary compostions for the treatment of parasitic diseases
JO2214B1
(en)
USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN
COMPOSITION OF FONDAPARINUX SODICO DE HIGH PURITY, A PROCEDURE FOR THE PREPARATION OF THIS COMPOSITION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT AS AN ACTIVE PRINCIPLE